Kodiak Sciences Inc. , a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases.
Kodiak Sciences stock last closed at $3.64, up 5.51% from the previous day, and has decreased 35.29% in one year. It has overperformed other stocks in the Biotechnology industry by 0.12 percentage points. Kodiak Sciences stock is currently +66.59% from its 52-week low of $2.19, and -68.62% from its 52-week high of $11.60.
As of Mar 14, 2025, there are 52.62M KOD shares outstanding. The market cap of KOD is $191.55M. In the past 24 hours, 236,057 KOD shares were traded.
You need an online brokerage account to access the NASDAQ market and buy KOD stock.
We believe that eToro is the best brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you need to fill out some personal information so you can buy KOD stock today.
Now that you've finished signing up on app for investing, you can securely and quickly fund your account:
Watch the tutorial below for more details depositing money into your new brokerage account.
Once you have decided on the best place to buy Kodiak Sciences stock, it's critical to evaluate their stock before you invest, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was created to help average investors do more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on KOD's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge KOD's true value.
Using relative valuations methods:
You can do additional valuation research on KOD's stock here.
Out of 3 Equities analysts who monitor KOD, the consensus analyst rating on KOD is a Hold
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Kodiak Sciences stock forecast page.
In the last year, executives and large shareholders at KOD have sold more shares than they have bought.
John A. Borgeson, Executive Vice President and Chief Financial Officer of KOD, was the latest KOD insider to sell. They sold $7,903.50 worth of KOD stock on Jun 17, 2024.
Dig into more about who owns KOD shares here.
No, Kodiak Sciences doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main order types:
Click the Open button and eToro will place your order.
If you need more help investing in stocks on eToro, watch the helpful video below:
Now that you own some shares in KOD, you'll want to keep up with your company.
Make a watchlist to track the most important metrics related to your KOD stock.
To reiterate, here are the 6 steps to buy Kodiak Sciences stock:
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to monitor your new investment in Kodiak Sciences, get started below.